...
机译:头颈部鳞状细胞癌细胞系中自分泌表皮生长因子受体配体的产生和西妥昔单抗的应答
Department of Otorhinolaryngology, Head and Neck Surgery, Lund University, 221 85, Lund, Sweden;
Department of Otorhinolaryngology, Head and Neck Surgery, Lund University, 221 85, Lund, Sweden;
Department of Otorhinolaryngology, Head and Neck Surgery, Lund University, 221 85, Lund, Sweden;
Department of Otorhinolaryngology, Head and Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan;
Department of Otorhinolaryngology, Head and Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan;
Department of Oncology, Lund University, 221 85, Lund, Sweden;
Department of Oncology, Lund University, 221 85, Lund, Sweden;
Cetuximab; Epidermal growth factor receptor; Prediction; Head and neck squamous cell carcinoma; TGF-alpha; Epigen;
机译:头颈部鳞状细胞癌细胞系中自分泌表皮生长因子受体配体的产生和西妥昔单抗反应。
机译:常氧表皮生长因子受体诱导的缺氧诱导因子-1-α,血管内皮生长因子和BNIP3在头颈部鳞状细胞癌细胞系中的体外研究:对抗表皮生长因子受体治疗的意义
机译:表皮生长因子受体和HER3的双重靶向MEHD7945A作为单疗法或与顺铂组合部分地克服了头部和颈部鳞状细胞癌细胞系中的西妥昔单抗
机译:表皮生长因子受体酪氨酸激酶抑制剂ZD1839(Iressa)通过独立于p53和MMP,uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:受体酪氨酸激酶网络由成纤维细胞生长因子受体表皮生长因子受体v-erb-b2红细胞白血病病毒致癌基因同源物2和肝细胞生长因子受体驱动头颈部鳞状上皮癌细胞系的生长和存活。
机译:表皮生长因子受体(EGFR)通路多态性作为西妥昔单抗毒性在西班牙人口局部晚期头颈部鳞状细胞癌(HNSCC)中的预测标记